Treatment of Acute Myocarditis in Giant-Cell Myocarditis
This protocol addresses the management of acute myocarditis occurring specifically in the setting of giant-cell myocarditis — a distinct clinical subtype with its own treatment approach.
Clinical scenario: Acute myocarditis in the context of giant-cell myocarditis. The identification of this subtype defines the applicable treatment pathway detailed in the full protocol.
Treatment Overview
The protocol involves specific immunosuppressive agents — including antithymocyte globulin — directed at this subtype.
The complete regimen, agent selection, sequencing, and clinical parameters are set out in the full protocol.
References
DOI: 10.1093/eurheartj/ehaf192
Giant-cell myocarditis
Antithymocyte Globulin (ATG); cyclophosphamide; rituximab
View source ↗